Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 References  













Tiazotic acid







Add links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  



In other projects  


●Wikimedia Commons
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

Tiazotic acid
Clinical data
Trade namesThiotriazoline; Tiokor
Identifiers

  • 2-[(5-Methyl-1H-1,2,4-triazol-3-yl)sulfanyl]acetic acid

CAS Number
PubChem CID
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.244.688 Edit this at Wikidata
Chemical and physical data
FormulaC5H7N3O2S
Molar mass173.19 g·mol−1
3D model (JSmol)

  • CC1=NC(=NN1)SCC(=O)O

  • InChI=InChI=1S/C5H7N3O2S/c1-3-6-5(8-7-3)11-2-4(9)10/h2H2,1H3,(H,9,10)(H,6,7,8)

  • Key:OJUNWHNRDPRNBR-UHFFFAOYSA-N

Tiazotic acid (brand names Thiotriazoline and Tiokor) is an antioxidant. It is used as a pharmaceutical drug for the treatment of ischemic heart disease in Russia, Ukraine, and Uzbekistan.[1][2]

It is used as its salt with morpholine.[3]

It has been studied for its potential to improve the cardiac effects of COVID-19.[4]

References

[edit]
  1. ^ "Tiazotic acid". Inxsight Drugs. National Center for Advancing Translational Sciences.
  • ^ Kadin DV, Chumak BA, Filippov AE, Shustov SB (2015). "[Thiotriazoline in the Treatment of Stable Angina Pectoris of II-III Functional Class]". Kardiologiia. 55 (8): 26–29. doi:10.18565/cardio.2015.8.26-29. PMID 26761968.
  • ^ Shishkina SV, Baumer VN, Khromileva OV, Kucherenko LI, Mazur IA (2017). "The formation of two thiotriazoline polymorphs: Study from the energetic viewpoint". CrystEngComm. 19 (17): 2394–2401. doi:10.1039/C7CE00117G.
  • ^ Belenichev I, Kucherenko L, Pavlov S, Bukhtiyarova N, Popazova O, Derevianko N, et al. (2022). "Therapy of post-COVID-19 syndrome: Improving the efficiency and safety of basic metabolic drug treatment with tiazotic acid (Thiotriazoline)". Pharmacia. 69 (2): 509–516. doi:10.3897/pharmacia.69.e82596.
    • Stub icon

    This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=Tiazotic_acid&oldid=1220649616"
    Categories: 
    ●Cardiovascular system drug stubs
     ●Drugs acting on the cardiovascular system
     ●Triazoles
     ●Thioethers
     ●Carboxylic acids
     Hidden categories: 
    ●Articles with short description
     ●Short description is different from Wikidata
     ●ECHA InfoCard ID from Wikidata
     ●Infobox drug articles with non-default infobox title
     ●Chemical pages without ChemSpiderID
     ●Chemical pages without DrugBank identifier
     ●Drugs missing an ATC code
     ●Drugs with no legal status
     ●Articles containing unverified chemical infoboxes
     ●All stub articles
      


    ●This page was last edited on 25 April 2024, at 02:07 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki